3 high quality ASX healthcare shares to buy in 2020

CSL Limited (ASX:CSL) shares are one of three in the healthcare sector that I think investors should buy in 2020…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One area of the market which I think has outstanding long term growth potential is the healthcare sector.

This is due to the growing demand for healthcare services globally because of ageing populations and increasing chronic disease burden.

In light of this, I think investing in the healthcare sector with a long term view could result in strong returns over the next decade.

Three healthcare shares that I would buy are listed below:

Cochlear Limited (ASX: COH)

One healthcare share to consider buying is Cochlear. It is a leading developer, manufacturer, and distributor of cochlear implantable devices for the hearing impaired globally. Its shares have provided market-beating returns for investors over the last decade and I believe it is well-placed to do the same over the next decade. This is thanks to its position as a leader in a structural growth market which has high barriers to entry and attractive demographics. According to the WHO, it has forecast there to be 1.5 billion people over the age of 65 by 2050, up from 524 million in 2010. I believe this bodes well for the company's future growth.

CSL Limited (ASX: CSL)

Another healthcare share to consider buying is CSL. I believe the quality of the biotherapeutics company's management team and its CSL Behring and Seqirus businesses means there's a strong probability of its shares being market beaters again over the next 10 years. CSL Behring is the global leader in plasma therapies and Seqirus is the second biggest in the influenza vaccines industry. I feel both businesses have outstanding long-term growth prospects due to their leading products and potentially lucrative development pipelines.

Nanosonics Ltd (ASX: NAN)

Nanosonics is an infection control specialist which I think could be a great long term investment. It is best-known as the company behind the industry-leading trophon EPR disinfection system for ultrasound probes. While I think this product alone has the potential to underpin solid earnings growth over the coming years, I'm excited also by the upcoming launch of several new products targeting unmet needs. If these are half as successful as the trophon EPR disinfection system, then Nanosonics will have a very bright future.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 exciting Australian growth shares to buy with $3,000 in August

Analysts think these shares could be top buys for Aussie growth investors.

Read more »

Young woman waiting for job interview.
Growth Shares

Australian job ad volumes declined last month. Are Seek shares a sell?

Should investors seek returns elsewhere?

Read more »

happy investor, share price rise, increase, up
Growth Shares

The best ASX growth shares to buy now

These growth shares have been recommended as buys.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Growth Shares

Where to invest $2,500 in ASX shares in August

Let's see which shares are being tipped as buys for next month.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

What to buy now with the ASX at a record high

Analysts think these shares could still rise strongly from current levels.

Read more »

A young man looks at a stylised investment graph superimposed on an exterior office building backdrop.
Growth Shares

Where to invest $10,000 in ASX 200 stocks today

Analysts think these high-quality shares are in the buy zone for investors right now.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Growth Shares

Two ASX industrials shares with buy recommendations

One broker believes these growth shares are set to rise.

Read more »

Man smiling at a laptop because of a rising share price.
Growth Shares

I think these 2 exciting ASX growth shares are buys today

These stocks could deliver big returns.

Read more »